Today's Spotlight: A First Lady for All of Us: On the Road with Dr. Jill Biden | Ohio’s Trans Sports Ban Stalls Yet Again After Governor Speaks Out Against It

Condé Nast Presents: Spotlight -- a Collection of Breaking-News and Top Stories from Across Our Iconic Brands

View this email in your browser  | Unsubscribe     Allure | Architectural Digest | Ars Technica | Bon Appétit | Condé Nast Traveler | Epicurious | Glamour | GQ GQ Style | La Cucina Italiana | The New Yorker | Pitchfork | Self | Teen Vogue | them | Vanity Fair | Vogue | Wired Did you know we have more themed newsletters like this one? Select your interests.     GQ    +Subscribe  Virgil Abloh Is Bringing the Nike Air Force 1 to Louis Vuitton Abloh's grand sneaker experiment comes full circle at Louis Vuitton. Read More     VOGUE    +Subscribe  A First Lady for All of Us: On the Road with Dr. Jill Biden She's driven, tireless, effortlessly popular—and no, she's not quitting her day job. READ MORE     THEM.    +Subscribe  Ohio's Trans Sports Ban Stalls Yet Again After Governor Speaks Out Against It Republican Mike DeWine said in a statement that the issue is best handled at the local level. READ MORE     ALLURE    +Subscribe  The Most Exciting New Skin-Care Products to Launch This Month Give your summer routine a kickstart with a refreshing cleansers and happy, hydrated lips. READ MORE GLAMOUR    +Subscribe  Here Are the 6 Women of the USA Gymnastics Olympic Team What are the stories behind Simone Biles's five teammates—Sunisa Lee, Jordan Chiles, Grace McCallum, Jade Carey, and MyKayla Skinner? READ MORE ARCHITECTURAL DIGEST    +Subscribe  A New Brazilian Design Gallery Is Making Waves in the Hamptons Tathiana Teixeira and Lilian Vianna-Benarroch opened Heritage Brazil this spring READ MORE EPICURIOUS    +Subscribe  This $18 Rosé Is the Wine of the Summer No matter what I'm cooking, it's the only thing I want to drink. READ MORE ARS TECHNICA    +Subscribe  Controversial Alzheimer's drug could cost US $334B—nearly half of DoD budget Despite unproven efficacy, Biogen set the drug's list price at $56,000 per year. READ MORE Unsubscribe   Privacy Policy Condé Nast One World Trade Center New York, NY 10007   © Condé Nast 2021, All rights reserved